ICAGEN, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementIcagen Inc • March 15th, 2011 • Pharmaceutical preparations • New York
Company FiledMarch 15th, 2011 Industry JurisdictionIcagen, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC (“MLV”), as follows: